<DOC>
	<DOCNO>NCT02292004</DOCNO>
	<brief_summary>This study assess safety early efficacy newly develop device , bridge-enhanced scaffold ( MIACH™ , ) use repair torn anterior cruciate ligament ( ACL . ) Ten participant undergo surgery new device ( Experimental Group ) 10 undergo standard ACL reconstruction surgery ( Control Group . )</brief_summary>
	<brief_title>Bridge-Enhanced ACL Repair-Safety Study ( BEAR Trial )</brief_title>
	<detailed_description>This first-in-human trial evaluation safety ( Primary Objective ) short-term efficacy ( Secondary Objective ) MIACH™ ACL scaffold carry form observational study 20 patient : 10 experimental 10 control .</detailed_description>
	<criteria>Complete ACL tear , confirm MRI Time injury screen must less equal 90 day ACL tissue present preoperative MRI Exclusion Criteria ( surgery ) : Prior surgery affect knee History prior infection affect knee Regular use tobacco nicotine form Use corticosteroid within last 6 month Ever underwent chemotherapy treatment History sickle cell disease History anaphylaxis Any condition could affect heal ( Diabetes , inflammatory arthritis , etc ) Diagnosis posterolateral corner injury ( LCL complete tear , Biceps femoris tendon avulsion , tear arcuate ligament , tear popliteus ligament ) Diagnosis Grade III medial collateral ligament injury Diagnosis complete patellar dislocation Exclusion Criteria ( surgery ) : ACL deem normal arthroscopic inspection Time injury surgery great 90 day ( Comparator group ) great 30 day ( Experimental group ) Experimental Group : Less 50 percent ACL remain Displaced bucket handle meniscal injury require repair Diagnosis fullthickness chondral injury either condyle Grade III medial collateral ligament injury</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>